RareWays is a research directory. It helps you understand the science. It is not medical advice. Always discuss your care options with your healthcare team.
Coverage: 2020-01-01 onwards, with up to 300 results per query from PubMed and Europe PMC and separate limits on other sources. This is a selected index, not a complete literature search.
Updates are delayed or unverified. Check original sources for the latest information.
Your saved research and appointment questionsView recorded trial and retraction changes
Burkitt Lymphoma: Research Summary
Printed from RareWays (rareways.org)
For general awareness only. Not medical advice. Discuss all care options with your healthcare team.
5 Most Recent Research Articles
- 1.
Burkitt Lymphoma Masquerading as Acute Abdomen: Imaging Insights from a Case Series
Ivan Mikhail, European Society of Radiology (19 October 2026)
https://doi.org/10.26044/ranzcr2026/c-226
- 2.
Selective Immune Tolerance: A Unifying Mechanism Linking Heavy Malaria Exposure, Waning Vaccine Antibodies, and Burkitt Lymphoma.
Bedsaul-Fryer Jacquelyn R et al., The Journal of infectious diseases (15 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42315117/
- 3.
Burkitt lymphoma: current understanding, unmet needs, and research directions.
Khan Adiba et al., Blood advances (13 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42448305/
- 4.
Epstein–Barr virus in paediatric sporadic Burkitt lymphoma: real-world experience from a Peruvian national referral centre
Sandro A. Casavilca-Zambrano et al., ecancermedicalscience (8 October 2026)
https://doi.org/10.3332/ecancer.2026.2230
- 5.
Scleral perforation in a young adult with Burkitt lymphoma.
Bálint Orsolya et al., BMJ case reports (7 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42843907/
Clinical Trials : Currently Recruiting (Australia)
Ask your doctor whether you or your child may be eligible for any of these trials. Each has its ID and full eligibility criteria at the link shown.
- 1.
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
NCT06395103 · Recruiting · Phase 1 / Phase 2 · Merck Sharp & Dohme LLC
Ages 6 Months to 25
https://clinicaltrials.gov/study/NCT06395103
Source: RareWays research directory. Data from PubMed, Europe PMC, OpenAlex, ClinicalTrials.gov.
Always verify information with your healthcare team before making any decisions about your care.
Burkitt Lymphoma
Burkitt lymphoma is a rare, fast-growing cancer of the B cells, a type of white blood cell. It can affect the lymph nodes, jaw, abdomen and other organs, and sometimes the bone marrow or brain and spinal fluid. It is treated with short, intensive courses of chemotherapy, often combined with rituximab, and many people are cured, especially children and young adults.
This overview is general information, not an individual medical assessment. Research is selected automatically and may include mismatches. How we select and explain research.
Most Recent Research
Common Questions
What is Burkitt Lymphoma?
Burkitt lymphoma is a rare, fast-growing cancer of the B cells, a type of white blood cell. It can affect the lymph nodes, jaw, abdomen and other organs, and sometimes the bone marrow or brain and spinal fluid. It is treated with short, intensive courses of chemotherapy, often combined with rituximab, and many people are cured, especially children and young adults.
How many clinical trials are available for Burkitt Lymphoma?
RareWays currently indexes 220 clinical trials for Burkitt Lymphoma, of which 21 are actively recruiting. These counts cover indexed trials across countries, not just your country. An Australian site does not necessarily mean that site is recruiting. Check locations, eligibility and current availability with the study team.
Where does the research data for Burkitt Lymphoma come from?
RareWays aggregates research from PubMed, Europe PMC, OpenAlex, and ClinicalTrials.gov. Data is refreshed automatically every day. All articles and trials link directly to their original sources.
Get research updates
Monthly email when new findings are published for Burkitt Lymphoma.
Your email and selected disease are stored for these updates. Unsubscribe any time. Privacy and deletion.
This information is for general awareness only.
For guidance specific to your situation, please speak with your healthcare team.